Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

被引：4
作者：
Sharma, Ashish [1 ,6 ]
Loewenstein, Anat [2 ]
Parachuri, Nikulaa [3 ]
Kumar, Nilesh [4 ]
Kuppermann, Baruch D. [5 ]
机构：
[1] Lotus Eye Hosp & Inst, Coimbatore, TN, India
[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Ophthalmol, Tel Aviv, Israel
[3] Sankara Eye Hosp, Dept Vitreoretina, Coimbatore, TN, India
[4] Madhavi Netralaya, Ara, Bihar, India
[5] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA USA
[6] Lotus Eye Hosp & Inst, Avinashi Rd, Coimbatore 641014, TN, India
来源：
JOURNAL OF VITREORETINAL DISEASES | 2023年 / 7卷 / 06期
关键词：
biosimilar; switch; retina; anti-VEGF;
D O I：
10.1177/24741264231202080
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 476
页数：3
相关论文
共 50 条
[21]   PATTERNS OF REFERRAL OF RETINAL PATIENTS FOR LOW VISION INTERVENTION IN THE ANTI-VEGF ERA [J].
Sunness, Janet S. ;
Schartz, R. Brandon ;
Thompson, John T. ;
Sjaarda, Raymond N. ;
Elman, Michael J. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (07) :1036-1039
[22]   Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion [J].
Nagasato, Daisuke ;
Muraoka, Yuki ;
Tanabe, Mao ;
Nishigori, Naomi ;
Osaka, Rie ;
Mitamura, Yoshinori ;
Tabuchi, Hitoshi ;
Murakami, Tomoaki ;
Ooto, Sotaro ;
Suzuma, Kiyoshi ;
Tsujikawa, Akitaka .
OPHTHALMOLOGY SCIENCE, 2024, 4 (02)
[23]   Resistance to anti-VEGF agents [J].
Ton, NC ;
Jayson, GC .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (01) :51-64
[24]   Prognostic modelling of number of patients with retinal vein occlusion in anti-VEGF therapy [J].
Subhi, Yousif ;
Potapenko, Ivan ;
Hajari, Javad N. N. ;
la Cour, Morten .
ACTA OPHTHALMOLOGICA, 2024, 102 (03) :318-325
[25]   Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients [J].
Peters, Bas J. M. ;
Bhatoe, Anish ;
Vorselaars, Adriane D. M. ;
Veltkamp, Marcel .
CELLS, 2021, 10 (02) :1-8
[26]   Predictors for Visual Outcome Prior to Anti-VEGF Therapy in Vascular Occlusive Diseases [J].
Wolf-Schnurrbusch, U. E. ;
Framme, C. ;
Rothenbuehler, S. P. ;
Wolf, S. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
[27]   Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery [J].
Konstantinos Andreanos ;
Petros Petrou ;
George Kymionis ;
Dimitrios Papaconstantinou ;
Ilias Georgalas .
BMC Ophthalmology, 17
[28]   Remote Monitoring of Patients with Retinal Vein Occlusions Treated with Anti-VEGF: A Pilot Study [J].
Castellino, Niccolo ;
Cappellani, Francesco ;
Dammino, Edoardo ;
Rubegni, Giovanni ;
Scollo, Davide ;
Russo, Andrea ;
Avitabile, Teresio ;
Longo, Antonio .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (07)
[29]   Anti-VEGF in diabetic retinopathy and diabetic macular edema [J].
Habbu, Karishma ;
Singh, Rishi P. .
EXPERT REVIEW OF OPHTHALMOLOGY, 2016, 11 (06) :443-451
[30]   QUANTITATIVE CHANGES IN RETINAL PIGMENT EPITHELIAL DETACHMENTS AS A PREDICTOR FOR RETREATMENT WITH ANTI-VEGF THERAPY [J].
Penha, Fernando M. ;
Gregori, Giovanni ;
Filho, Carlos Alexandre de Amorim Garcia ;
Yehoshua, Zohar ;
Feuer, William J. ;
Rosenfeld, Philip J. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (03) :459-466
12345